Purdue sues its insurers for $3.3bn of opioid litigation coverage

Purdue Pharma has sued its insurers, seeking a ruling that it is entitled to $3.3bn of coverage under its policies to help pay some of the liability the OxyContin maker faces from thousands of opioid mass tort claims.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com